A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Clinical trial NCT04837508 · UNKNOWN
Trial details
- NCT number
- NCT04837508
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2022-12-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.